Concepedia

Rodney C. Schnur

RC

Statistics

Publications

20

Citations

1.3K

H-Index

15

Active since

1975

Affiliations

Pfizer (United States)(Current)

Pennsylvania State University

National Cancer Institute

Rodney C. Schnur is an author at Pfizer (United States) specializing in pharmacology, medicinal chemistry, and enzyme inhibition.

Publications per year

1975–1997

20

Publications

20

p185erbB2 Binds to GRP94 in Vivo

Christine Chavany, Edward G. Mimnaugh, Penny E. Miller et al. · Journal of Biological Chemistry · 1996 · 258 citations · Full text

, , +10

Inhibition of the oncogene product p185erbB-2 in vitro and in vivo by geldanamycin and dihydrogeldanamycin derivatives

Rodney C. Schnur, Michael L. Corman, Randall J. Gallaschun et al. · Journal of Medicinal Chemistry · 1995 · 199 citations

, , +7

erbB-2 oncogene inhibition by geldanamycin derivatives: synthesis, mechanism of action, and structure-activity relationships

Rodney C. Schnur, Michael L. Corman, Randall J. Gallaschun et al. · Journal of Medicinal Chemistry · 1995 · 139 citations

, , +11

Selective N-dealkylation of tertiary amines with vinyl chloroformate: An improved synthesis of naloxone

R. A. Olofson, Rodney C. Schnur, Leonard Bunes et al. · Tetrahedron Letters · 1977 · 115 citations

, , +5

Depletion of the erbB-2 gene product p185 by benzoquinoid ansamycins.

Penny E. Miller, C DiOrio, Mary Pat Moyer et al. · PubMed · 1994 · 113 citations

, , +15

1–5 of 20